, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Assessing cardiac safety in oncology drug development.

Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF
Am Heart J. 2019 214: 125-133

PMID: 31202099 · PMCID: PMC7316329 · DOI:10.1016/j.ahj.2019.04.010

MeSH Terms (16)

Antineoplastic Agents Antineoplastic Agents, Immunological Biomarkers Cardiologists Cardiovascular Diseases Cell Line, Tumor Clinical Trials as Topic Data Collection Drug Development Drug Screening Assays, Antitumor Heart Humans Immunotherapy Medical Oncology Research Design Trastuzumab

Connections (1)

This publication is referenced by other Labnodes entities:

Links